Covid-19: 130 Countries Yet To Receive Vaccine, WHO Cries Out

Related stories

Niger Junta Restores Order After Insurgents Attempt to Storm Presidential Palace

By Afolayan Sunday Niger's ruling military administration announced it has...

Shettima Jets Out of Abuja to Attend AU Summit in Angola

By Afolayan Sunday Vice President Kashim Shettima has departed Abuja...

Nigeria’s Land Borders Are Open, Tunji-Ojo Fires Back at Atiku

By Abiola Olawale The Minister of Interior, Hon. Olubunmi Tunji-Ojo,...

Chinese Suspects Flee as Police Rescue 2 Colombians

By Nwosa Hamilton The Nigeria Police Force has rescued two...

Details as Shettima Opts for Low-Key 60th Birthday Celebration

By Abiola Olawale Vice President Kashim Shettima has officially announced...

The World Health Organisation (WHO) said three-quarters of all COVID-19 vaccinations were only in 10 countries, accounting for almost 60 per cent of global Gross Domestic Product (GDP).

According to WHO, 130 countries are yet to get the vaccines to inoculate citizens against the virus.

“Around 130 countries, with 2.5 billion people, are yet to administer a single dose”, WHO Director-General, Dr Tedros Ghebreyesus said at a regular press briefing on COVID-19, in Geneva, on Friday.

“On Wednesday, COVAX published its forecast for the distribution of vaccines to participating countries. Countries are ready to go, but the vaccines aren’t there. We need countries to share doses, once they have finished vaccinating health workers and older people.

“We also need a massive scale-up in production. Manufacturers can do more: having received substantial public funding, we encourage all manufacturers to share their data and technology to ensure global equitable access to vaccines.’’

Ghebreyesus repeated his call on companies to share their dossiers with WHO faster and more fully than they have been doing so that the organisation would review them for emergency use listing.

Similarly, he called on companies to emulate last week’s announcement by French pharmaceutical giant Sanofi that it would make its manufacturing infrastructure available for the production of the Pfizer/BioNTech vaccine.

“Companies can also issue non-exclusive licenses to allow other producers to manufacture their vaccine – a mechanism that has been used before to expand access to treatments for HIV and hepatitis C,’’ he said.

'Dotun Akintomide
'Dotun Akintomide
'Dotun Akintomide's journalism works intersect business, environment, politics and developmental issues. Among a number of local and international publications, his work has appeared in the New York Times. He's a winner of the National Youth Service Corps (NYSC) Award. Currently, the Online Editor at The New Diplomat, Akintomide has produced reports that uniquely spoke to Nigeria's experience on Climate Change issues. When Akintomide is not writing, volunteering or working on a media project, you can find him seeing beautiful sites like the sandy beaches that bedecked the Lagos coastline.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from up to 5 devices at once

Latest stories